2008Zhongguo xiandai yixue/Zhongguo xiandai yixue zazhiRequires access

Efficacy of short-term glucocorticoid and plasma exchange in treatment of patients with hepatitis B accompanied with hyperbilirubinemia

Ping Hu

Open publisher page 0 citations

Abstract

[Objective] To observe the efficacy of short-term glucocorticoid and plasma exchange (PE) in the treatment of patients with viral hepatitis B accompanied with hyperbilirubinemia. [Method] 34 patients with hepatitis B accompanied with hyperbilirubinemia were divided into two groups: treatment group and control group. Two groups of patients were treated with PE. In the patients of treatment group, 10 mg Dexamethasone was intravenously given daily for 5 days after PE. Serum levels of bilirubin were compared in two groups right after PE, 4 days after PE and 7 days after PE, respectively. [Results] Serum levels of total bilirubin(TB) in two groups right after PE were significantly decreased compared with those before PE (P 0.01). In control group, serum level of total bilirubin significantly increased 4 days after PE compared with that right after PE (P 0.05), whereas in the patients of treatment group, the serum total bilirubin level steadily decreased and TB on day 7 after PE was significantly lower than that in control group (P 0.05). No significant side-effects were observed in both groups. [Conclusion] For the treatment of patients with hepatitis B accompanied with hyperbilirubinemia, short-term glucocorticoid and PE are effective, economical and safe.

About this research paper

What this paper is about

[Objective] To observe the efficacy of short-term glucocorticoid and plasma exchange (PE) in the treatment of patients with viral hepatitis B accompanied with hyperbilirubinemia. [Method] 34 patients with hepatitis B accompanied with hyperbilirubinemia were divided into two groups: treatment group and control group. Two groups of patients were treated with PE. In the patients of treatment group, 10 mg Dexamethasone was intravenously given daily for 5 days after PE. Serum levels of bilirubin were compared in two groups right after PE, 4 days after PE and 7 days after PE, respectively. [Results] Serum levels of total bilirubin(TB) in two groups right after PE were significantly decreased compared with those before PE (P 0.01). In control group, serum level of total bilirubin significantly increased 4 days after PE compared with that right after PE (P 0.05), whereas in the patients of treatment group, the serum total bilirubin level steadily decreased and TB on day 7 after PE was significantly lower than that in control group (P 0.05). No significant side-effects were observed in both groups. [Conclusion] For the treatment of patients with hepatitis B accompanied with hyperbilirubinemia, short-term glucocorticoid and PE are effective, economical and safe.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

[Objective] To observe the efficacy of short-term glucocorticoid and plasma exchange (PE) in the treatment of patients with viral hepatitis B accompanied with hyperbilirubinemia. [Method] 34 patients with hepatitis B accompanied with hyperbilirubinemia were divided into two groups: treatment group and control group. Two groups of patients were treated with PE. In the patients of treatment group, 10 mg Dexamethasone was intravenously given daily for 5 days after PE. Serum levels of bilirubin were compared in two groups right after PE, 4 days after PE and 7 days after PE, respectively. [Results] Serum levels of total bilirubin(TB) in two groups right after PE were significantly decreased compared with those before PE (P 0.01). In control group, serum level of total bilirubin significantly increased 4 days after PE compared with that right after PE (P 0.05), whereas in the patients of treatment group, the serum total bilirubin level steadily decreased and TB on day 7 after PE was significantly lower than that in control group (P 0.05). No significant side-effects were observed in both groups. [Conclusion] For the treatment of patients with hepatitis B accompanied with hyperbilirubinemia, short-term glucocorticoid and PE are effective, economical and safe.

Key concepts: Medicine, Glucocorticoid, Bilirubin, Internal medicine, Gastroenterology, Dexamethasone, Hepatitis a virus, Hepatitis

Related papers

Back to paper searchBrowse research topicsOriginal source
Efficacy of short-term glucocorticoid and plasma exchange in treatment of patients with hepatitis B accompanied with hyperbilirubinemia — Research Paper | ScholarLens